AzTrials
AzTrials

DepressionNCT07771413

Effect of a Telehealth Intervention on Depressive Symptoms Among Caregivers of Patients With Cerebral Palsy Receiving Home Care

A study testing Behavioral Treatment in people with Depression, run by Gülhane Research and Education Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this pilot intervention study is to assess the feasibility of applying Lewinsohn's Multifactoral Integrative Model of Depression to caregivers of patients with cerebral palsy. Caregivers received a four-week telehealth intervention based on the model. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Depression
What is being tested?
Behavioral Treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
1 siteTurkey (Türkiye)
Study dates
10 Nov 2025to 20 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • have a child who diagnosed cerebral palsy
  • have adequate cognitive ability
  • 18 years or older
  • BDI score ≥3

Who cannot join

  • under 18 years old
  • BDI score <3
  • cognitive impairment
  • not being a caregiver of cerebral palsy

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Gülhane Research and Education Hospital

    Ankara, Ankara, 06000

Other trials in Turkey (Türkiye)

About this study

The aim of this pilot intervention study is to assess the feasibility of applying Lewinsohn's Multifactoral Integrative Model of Depression to caregivers of patients with cerebral palsy. Caregivers received a four-week telehealth intervention based on the model. Depression levels were assessed before and after the intervention to explore preliminary changes in depressive symptoms.

Read the detailed description

This pilot intervention study evaluated the feasibility of a four-week telehealth intervention based on Lewinsohn's Multifactoral Integrative Model of Depression among caregivers of patients with cerebral palsy receiving home healthcare services. The intervention was designed to address factors associated with depressive symptoms within the framework of the model and was delivered over four weeks through four planned sessions.

Caregivers who met the eligibility criteria participated in the intervention. Depression and anxiety symptoms were assessed before and after the intervention using validated self-report measures.

The study primarily aimed to evaluate the feasibility of the intervention and to obtain preliminary estimates of changes in depressive symptoms that could inform the design of a future controlled trial. Because this was a pilot study with a single intervention group and a small sample, the findings are intended to provide preliminary evidence regarding the feasibility of the intervention and to inform the design of a future controlled study.

Conditions
Depression
Being tested
Behavioral Treatment
Keywords
depression, caregiver burden, pilot intervention, cerebral palsy
Medical subject headings
Depression, Caregiver Burden, Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Behavioral TreatmentBehavioural

    Caregiver's took behavioral intervention model via telephone every four week, same day at same hour

Study groups in NCT07771413
Study groupRoleWhat they receive
telehealth interventionExperimentalThey took Lewinsohn's Multifactoral Integrative Model of Depression via telephone four weeks
Receives: Behavioral: Behavioral Treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Depression

    Beck Depression Inventory-I was used in this study. People fill out this inventory with reviewing their last week and scores summed up for total scores. Results were meant 0-9=minimal depression, 10-16=mild, 17-29= moderate, 30-63= severe depression

    Measured: Baseline to post-intervention (four weeks)

Secondary outcomes (1)
  1. Anxiety

    Beck Anxiety Inventory was used in this study for evaluate the frequency of individuals' symptoms of anxiety for adults.It is a self-report inventory and has twenty-one questions and third-degree Likert scale.

    Measured: Baseline to post-intervention (four weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Aug 2026
  2. Study start10 Nov 2025
  3. Primary completion5 Jan 2026
  4. Study completion20 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07771413
Sponsor's protocol ID
GUREH-CG-2025-369
Status last verified
Aug 2026
First submitted
13 Aug 2026
Last updated
21 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data underlying the reported results will be shared, including demographic characteristics, baseline and post-intervention depression and anxiety scores, caregiver burden scores, and relevant clinical and caregiving characteristics.

Questions about this trial

What is this clinical trial studying?

A study testing Behavioral Treatment in people with Depression, run by Gülhane Research and Education Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Depression (time frame: Baseline to post-intervention (four weeks)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in